A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...
Emboline's Emboliner system excels in a global trial, showing superior debris capture and procedural success in TAVR patients ...
The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...
CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...
SANTA CRUZ, Calif., March 12, 2024 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results